The subclass distribution of IgG-producing immunocytes was studied by two colour immunohistochemistry with monoclonal antibodies in jejunal biopsy specimens from 10 adults with untreated coeliac disease, 11 coeliac disease patients on a gluten free diet, and seven patients with established food allergy. Paired immunofluorescence staining was performed with subclass specific murine monoclonal antibodies in combination with polyclonal rabbit antibody reagent to total IgG; the proportion of cells belonging to each subclass could thereby be determined. The ratio of IgG2 immunocytes was significantly higher (p<005) in untreated coeliac disease patients (median, 35.2%; range, 26.7-65-2%) than in those on a gluten free diet (median, 7.3%; range, 0-31V9%) or those having food allergy (median, 12.5%; range, 0-36.5%). The disparity in the local IgG2 response between patients with untreated coeliac disease and those with food allergy might be due to differences in the nature of the antigenic stimuli, dissimilar genetic 'make-up' of the subjects, or both.
immunological factors and might be of great interest for the understanding of disease processes.
A recent study in the United States`suggested that persistently raised serum antibody concentrations to gliadin in adult coeliac disease after treatment with a gluten free diet (GFD), occurred only in patients with the chromosome 14-encoded IgG2 heavy-chain allotype marker G2m(n). This observation could not be confirmed by others, however."' In addition to such genetically determined variation, it has been shown that various viral and bacterial antigens or mitogens may stimulate B cells to produce different IgG subclasses both in v,itro" and in ViV,O."1
The purpose of the present study was to determine the IgG-subclass distribution of mucosal immunocytes in untreated coeliac disease compared with that found in treated coeliac disease patients and in patients suffering from food allergy. The distribution of the IgG heavy-chain marker (Gm) in the patients and in a control group of healthy blood donors was also determined.
Methods PAFIENTS AND [ISSUE SPECIMENS
Twenty eight subjects with adverse reactions to food were studied. They included 10 patients with coeliac disease who were untreated and 11 coeliac disease patients on gluten free diet. The coeliac disease diagnosis was based on clinical investigation, intestinal biopsy'1 (Table 1) , and levels of serum antibodies to gluten6 14 ( Table 2 ). All coeliac disease patients responded to gluten restriction, and follow up examinations did not disclose other conditions associated with villous atrophy.
Seven patients with abdominal complaints who had a positive history of food allergy (Table 3 ) and a sufficient number of IgG-producing immunocytes for differential subclass-counting in the biopsy specimens were also included. Five of the latter had positive skin prick test for relevant foods and five had IgE positive mucosal mast cells (Table 3) -IV   3  52 F   -IV   3  4  27  F   -IV  2   5   31  M   -IV   2  6  59 F   -IV   3  7  39  F   -IV   8   73 F   -IV  2   9  81  F   -IV   3  10 19 F In this control experiment virtually all positive immunocytes showed both red and green fluorescence (Fig. 2e) . The coefficient of correlation (r) was 0.996 (Fig. 2f) . Purely green or red cells were extremely rare. This result showed that the paired staining procedure used for individual IgG subclasses was highly reliable.
IOCAI IgG RESPONSE, SEKUM ANTIIODIIS TO GI.UTIEIN, AND Gill IYI'INCG Untreated coeliac disease patients had significantly (p<0-05) increased serum IgG or IgA ELISA activities to gluten compared with both treated coeliac disease patients and patients with food allergy (Table 2) . A positive correlation (r=0-45, p=005) was found between the density of jejunal IgG2 subclass producing cells and the serum concentrations of IgG gluten antibodies in treated and untreated coeliac disease patients. No significant correlation was found betwecin the detnsity of total IgG cells atnd the serum levels of gluten IgG antibodies ( Table   2 ).
The frequency of the Gm marker n was 72% in the coeliac disease patients tested (six treated and seven untreated), 71% in the patients with food allergy, and 70% in the healthy blood donors. Thus, these frequencies and also those of the other IgG heavy chain allotype markers (data not shown), were not different.
Discussion
A mucosal IgG response has previously been suggested to be of pathogenic importance in coeliac disecase,' anId it was ot' initerest to studv the subclass pattern of this reponse. Here we report that the proportion of duodenal IgG2-producing cells was found to be significantly increased in untreated coeliac disease patients compared with treated ones and with patients who had food allergy.
Because of the scarcity of IgG immunocytes in healthy gut mucosa,' we were unable to evaluate the subclass pattern in normal control specimens.
Our results indicated that the mucosal immune response in coeliac disease includes -in addition to IgA, IgM and IgG, in that order' a preferential local expansion of the IgG2 cell population. The proportion of mucosal IgG2 cells found in untreated coeliac disease was similar to that seen in Crohn's disease of the colon. 4 Conversely, in ulcerative colitis we observed a disproportionate expansion of the IgG I cell population.4 In normal nasal mucosa we often found a preference of IgG3-over IgG2-producing cells," thus contrasting that seen in inflamed intestinal mucosa -probably because of differences in the nature of antigenic stimulation at the two mucosal sites.
The relatively prominent jejunal IgG2 response in untreated coeliac disease may hence be directly related to gluten ingestion. A possible role of IgG2 in the pathogenesis of coeliac disease, however, remacins obscure. As' IgG2 has relatively little complement activating capacity" and shows poor Fc receptor binding,`4 it is unlikely that this subclass is important in the perpetuation of coeliac disease as we previously suggested for IgG antibodies on the basis of our observations of the total mucosal IgG response.' IgG2 may, instead, be involved in local protective mechanisms in concert with the stimulated secretory IgA and IgM system.'
The present finding of a prominent mucosal IgG2 response is of interest in light of the conflicting results reported on the IgG subclass distribution of gliadin antibodies in serum. Such antibodies have been described in all of the IgG subclasses, but mainly in the IgG1 subclass."
The relatively weak but significant correlation between local IgG2 cell response and serum concentrations of IgG antibodies to gluten seen in our study, suggested a possible contribution of serum IgG from mucosal production. Regional lymph nodes seeded by gluten stimulated mucosal immunocytes, however, may be an even more important source of such antibodies. We 
